Role of the PNPLA3 I148M Polymorphism in Nonalcoholic Fatty Liver Disease and Fibrosis in Korea

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Digestive Diseases and Sciences

• Publication date

  2014-07-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10620-014-3279-zPMID 25069572
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Effect of PNPLA3 on Fibrosis Progression and Development of Hepatocellular Carcinoma: A Meta-analysis

  2014cited by this paper
• Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease.

  2013cited by this paper
• Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan

  2013cited by this paper
• Cohort Study of Non-alcoholic Fatty Liver Disease, NAFLD fibrosis score, and the Risk of Incident Diabetes in a Korean population

  2013cited by this paper
• Genetic Polymorphisms of the Human PNPLA3 Gene Are Strongly Associated with Severity of Non-Alcoholic Fatty Liver Disease in Japanese

  2012cited by this paper
• I148M PNPLA3 variant and progressive liver disease: a new paradigm in hepatology.

  2012cited by this paper
• Genetic variant in PNPLA3 is associated with nonalcoholic fatty liver disease in China

  2012cited by this paper
• A multi-ethnic study of a PNPLA3 gene variant and its association with disease severity in non-alcoholic fatty liver disease

  2012cited by this paper
• Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase.

  2012cited by this paper
• Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro.

  2012cited by this paper
• I148M PNPLA3 variant and progressive liver disease: A new paradigm in hepatology

  2012cited by this paper
• The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population

  2011cited by this paper
• A common variant in the PNPLA3 gene is a risk factor for non-alcoholic fatty liver disease in obese Taiwanese children.

  2011influential reference
• Comparison of NAFLD fibrosis score and BARD score in predicting fibrosis in nonalcoholic fatty liver disease.

  2011cited by this paper
• Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults

  2011cited by this paper
• Nonalcoholic fatty liver in Asia: Firmly entrenched and rapidly gaining ground

  2011cited by this paper
• Meta‐analysis of the influence of I148M variant of patatin‐like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease

  2011cited by this paper
• Patatin‐like phospholipase domain containing‐3 Ile148Met and fibrosis progression after liver transplantation

  2011cited by this paper
• Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

  2011influential reference
• Genome-Wide Association Analysis Identifies Variants Associated with Nonalcoholic Fatty Liver Disease That Have Distinct Effects on Metabolic Traits

  2011cited by this paper
• Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease

  2010cited by this paper
• PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease

  2010cited by this paper
• Variant in PNPLA3 is associated with alcoholic liver disease

  2010cited by this paper
• Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians

  2010cited by this paper
• The association of genetic variability in patatin‐like phospholipase domain‐containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease

  2010cited by this paper
• Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease

  2010cited by this paper
• A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity

  2009cited by this paper
• A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans

  2009cited by this paper
• Current status of liver disease in Korea: nonalcoholic fatty liver disease.

  2009cited by this paper
• Current status of liver diseases in Korea: hepatitis A.

  2009cited by this paper
• Current status of liver diseases in Korea: hepatitis B.

  2009cited by this paper
• Dissociation Between Fatty Liver and Insulin Resistance in Humans Carrying a Variant of the Patatin-Like Phospholipase 3 Gene

  2009cited by this paper
• A Sequence Variation (I148M) in PNPLA3 Associated with Nonalcoholic Fatty Liver Disease Disrupts Triglyceride Hydrolysis

  2009cited by this paper
• Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

  2008cited by this paper
• Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease

  2008cited by this paper
• The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

  2007cited by this paper
• Prevalence and risk factors of non‐alcoholic fatty liver disease among Korean adults

  2006cited by this paper
• Expression, regulation, and triglyceride hydrolase activity of Adiponutrin family members Published, JLR Papers in Press, September 8, 2005. DOI 10.1194/jlr.M500290-JLR200

  2005cited by this paper
• Nonalcoholic fatty liver disease

  2005cited by this paper
• A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C

  2003cited by this paper
• AGA technical review on nonalcoholic fatty liver disease.

  2002cited by this paper
• Adiponutrin : a transmembrane protein corresponding to a novel dietary-and obesity-linked mRNA specifically expressed in the adipose lineage

  2001cited by this paper
• Nonalcoholic fatty liver disease.

  1986cited by this paper

• The global landscape of lean metabolic dysfunction-associated steatotic liver disease: insight from Asia and the West

  2025influential citation
• DPP4 rs17574 polymorphism and elevated DPP4 levels linked to fatty liver in subclinical atherosclerosis: GEA study findings

  2025cites this paper
• The PNPLA3 148M variant exacerbates alcohol-induced liver injury and tumorigenesis in mice.

  2025cites this paper
• Ways to overcome difficulties in diagnosing non-alcoholic fatty liver disease

  2024cites this paper
• Tissue Inhibitor of Metalloproteinase 2 (TIMP 2) Promotor 418 G > C Polymorphism in Non-alcoholic Fatty Liver Disease (NAFLD) Patients of Eastern States of India

  2024cites this paper
• Genotypic variation in CYP2E1, GCKR, and PNPLA3 among nonalcoholic steatohepatitis patients of Turkish origin

  2024cites this paper
• Patatin-like phospholipase domain-containing 3 gene (PNPLA3) polymorphic (rs738409) single nucleotide polymorphisms and susceptibility to nonalcoholic fatty liver disease: A meta-analysis of twenty studies

  2023cites this paper
• Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive Analysis

  2023cites this paper
• Genetic Polymorphisms and Diversity in Nonalcoholic Fatty Liver Disease (NAFLD): A Mini Review

  2022cites this paper
• Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease: a systematic review and meta-analysis

  2021cites this paper
• Prevalence of the Absence of Cirrhosis in Subjects with NAFLD-Associated Hepatocellular Carcinoma

  2021cites this paper
• Effects of PNPLA3, TM6SF2 and SAMM50 on the development and severity of non‐alcoholic fatty liver disease in children

  2021cites this paper
• Frequency of I148M Polymorphism of the PNPLA3 Gene Associated with a Risk of Steatosis and Liver Fibrosis in Residents of the Republic of Sakha (Yakutia)

  2021influential citation
• Liver Cirrhosis as the Outcome of Non-Alcoholic Fatty Liver Disease Associated with PNPLA3 Gene RS738409 Polymorphism

  2020influential citation
• Связь цирроза печени в исходе неалкогольной жировой болезнью печени с полиморфизмом гена PNPLA3 rs738409

  2020cites this paper
• The effect of PNPLA3 polymorphism as gain in function mutation in the pathogenesis of non-alcoholic fatty liver disease

  2020cites this paper
• Nonalcoholic fatty liver disease and alcohol-related liver disease: From clinical aspects to pathophysiological insights

  2020cites this paper
• Impact of Glucoraphanin-Mediated Activation of Nrf2 on Non-Alcoholic Fatty Liver Disease with a Focus on Mitochondrial Dysfunction

  2019cites this paper
• Diagnosis and management of non-alcoholic fatty liver disease

  2019cites this paper
• A small supernumerary marker chromosome resulting in mosaic partial tetrasomy 4q26-q31.21 in a foetus with multiple congenital malformations

  2019cites this paper
• Genetics of nonalcoholic fatty liver disease in Asian populations

  2019influential citation
• PNPLA3 rs738409 underlies treatment response in nonalcoholic fatty liver disease

  2018cites this paper
• Combination of PNPLA3 and TLL1 polymorphism can predict advanced fibrosis in Japanese patients with nonalcoholic fatty liver disease

  2018cites this paper
• Additive effects of PNPLA3 and TM6SF2 on the histological severity of non‐alcoholic fatty liver disease

  2018cites this paper
• Risk Factors for the Development of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Genetics.

  2018cites this paper
• Effect of PNPLA3 I148M polymorphism on histologically proven non‐alcoholic fatty liver disease in liver transplant recipients

  2018cites this paper
• Clinical-morphological parallels of the PNPLA3 gene polymorphism in patients with nonalcoholic fatty liver disease.

  2018cites this paper
• PNPLA3 rs1010023 Predisposes Chronic Hepatitis B to Hepatic Steatosis but Improves Insulin Resistance and Glucose Metabolism

  2017cites this paper
• Development of hepatocellular carcinoma in Japanese patients with biopsy‐proven non‐alcoholic fatty liver disease: Association between PNPLA3 genotype and hepatocarcinogenesis/fibrosis progression

  2017cites this paper
• Association of single nucleotide polymorphism at PNPLA3 with fatty liver, steatohepatitis, and cirrhosis of liver

  2017cites this paper
• Association of the I148M/PNPLA3 (rs738409) polymorphism with premature coronary artery disease, fatty liver, and insulin resistance in type 2 diabetic patients and healthy controls. The GEA study.

  2017cites this paper
• Alcoholic Liver Disease in Asia, Europe, and North America.

  2016cites this paper
• PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease

  2016cites this paper
• Association of patatin-like phospholipase domain-containing protein 3 gene polymorphisms with susceptibility of nonalcoholic fatty liver disease in a Han Chinese population

  2016cites this paper
• The Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic Background

  2016cites this paper
• Assessment nonalcoholic fatty liver disease fibrosis score for staging and predicting outcome

  2016cites this paper
• Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review.

  2016cites this paper
• PNPLA3 as a Genetic Determinant of Risk for and Severity of Non-alcoholic Fatty Liver Disease Spectrum

  2016cites this paper
• Association Between Patatin-Like Phospholipase Domain Containing 3 Gene (PNPLA3) Polymorphisms and Nonalcoholic Fatty Liver Disease: A HuGE Review and Meta-Analysis

  2015cites this paper
• I148M variant in PNPLA3 reduces central adiposity and metabolic disease risks while increasing nonalcoholic fatty liver disease

  2015cites this paper
• The Impact of PNPLA3 rs738409 Genetic Polymorphism and Weight Gain ≥10 kg after Age 20 on Non-Alcoholic Fatty Liver Disease in Non-Obese Japanese Individuals

  2015cites this paper
• Genome-wide mRNA-seq profiling reveals predominant down-regulation of lipid metabolic processes in adipose tissues of Small Tail Han than Dorset sheep.

  2015cites this paper